Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Hardware-based parser for packet-oriented protocols
Method and apparatus for developing process
Motor for a synchronous electric machine and method for routing power
Arrangement for and method of examining gemstones
Nasal dilator
Retinal prosthesis techniques
Exposure apparatus, and device manufacturing method
  Randomly Featured Patents
Switch assembly including cam operated pivoted contact
System for surveillance of spectral signals
Automatic IF selectivity for radio receiver system
Methods and apparatuses for servicing load instructions
Precision steer wheel control system with external solenoid
Method and system for message transmission and reception
Magnetic resonance apparatus gantry and magnetic resonance apparatus
Multi-outlet adaptor for plug-in telephones
Presenting driving directions
Choke transformer used in liquid crystal display backlight driver